glp 1 and eating disorders GLP-1 Receptor Agonists Research to Treat Overeating and Substance Use Eating Disorder Therapy Vs. Ozempic

Type 2 diabetes patients taking GLP-1 drugs were overall less likely to die within the next year, but those with sleep apnea did even better, researchers reported Monday at a meeting of the American College of Chest Physicians in Chicago

But the generic versions of these peptides are more likely to be manufactured through entirely synthetic methods

An RCT in 36 patients with type 2 diabetes found that NAC (1,200 mg/day for 4 weeks) combined with a standard diabetes diet significantly reduced fasting glucose, HbA1c, and markers of oxidative stress compared to diet alone (Shahidi et al., J Diabetes Metab Disord, 2020) [56]

Please watch this video for further instructions